Global multinational Bayer has affirmed its position and robust presence in Kenya.

This follows an announcement made by Bayer earlier in the year about the transformation of their Pharmaceuticals and Consumer Health business models in East Africa.

The transformation, dubbed ‘Smart Serve,’ took effect on May 1, 2024, and leverages the expertise  and  networks of Imperial Distributors, a leading distributor for healthcare products, to ensure sustained availability and access to Bayer products and solutions In Kenya and East Africa at large.

Speaking about the transformation, Jorge Levinson, Bayer’s Cluster Lead for the Pharmaceuticals Division in Sub-Saharan Africa, reiterated the importance of the partnership and reaffirmed Bayer’s commitment to serving Kenya and other markets.

“We are pleased with the transformation of our business model to collaborate with experts towards achieving our mission.

“A key part of this transformation is to simplify our value chain, reduce lead time between production and distribution, and hence reach more patients and customers. We are happy that with this model, our products are now easily and readily accessible across Kenya. Through this model, we have also seen more professionals employed than we had employed directly,” said Jorge

In the new business model, Bayer is outsourcing transportation, local warehousing, distribution, and customer support to Imperial Distributors.

Imperial is handling the distribution aspect of the value chain, while Bayer’s legal entities in Kenya continue to manage business-related corporate affairs, including medical affairs, media relations, and stakeholder management such as government and partner relations.

The Smart Serve transformation furthers Bayer’s mission. It is about ensuring Bayer products are easily and more available in Kenya and beyond.

With this new model, Bayer is reaching and impacting more people in Africa.